Boston Common Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.9M | Buy |
35,763
+8,468
| +31% | +$6.6M | 0.78% | 35 |
|
|
2025
Q1 | $22.5M | Buy |
27,295
+3,267
| +14% | +$2.7M | 0.68% | 46 |
|
|
2024
Q4 | $18.5M | Buy |
24,028
+5,465
| +29% | +$4.22M | 0.54% | 67 |
|
|
2024
Q3 | $16.4M | Buy |
18,563
+8,106
| +78% | +$7.18M | 0.43% | 91 |
|
|
2024
Q2 | $9.47M | Buy |
10,457
+600
| +6% | +$543K | 0.24% | 128 |
|
|
2024
Q1 | $7.67M | Sell |
9,857
-247
| -2% | -$192K | 0.18% | 155 |
|
|
2023
Q4 | $5.89M | Sell |
10,104
-287
| -3% | -$167K | 0.13% | 189 |
|
|
2023
Q3 | $5.58M | Buy |
10,391
+4,253
| +69% | +$2.28M | 0.13% | 186 |
|
|
2023
Q2 | $2.88M | Buy |
+6,138
| New | +$2.88M | 0.06% | 237 |
|
|
2023
Q1 | – | Sell |
-2,825
| Closed | -$1.03M | – | 332 |
|
|
2022
Q4 | $1.03M | Buy |
2,825
+66
| +2% | +$24.1K | 0.05% | 162 |
|
|
2022
Q3 | $892K | Buy |
2,759
+35
| +1% | +$11.3K | 0.05% | 167 |
|
|
2022
Q2 | $883K | Buy |
2,724
+233
| +9% | +$75.5K | 0.04% | 178 |
|
|
2022
Q1 | $713K | Sell |
2,491
-298
| -11% | -$85.3K | 0.03% | 189 |
|
|
2021
Q4 | $770K | Buy |
2,789
+151
| +6% | +$41.7K | 0.03% | 185 |
|
|
2021
Q3 | $610K | Buy |
2,638
+6
| +0.2% | +$1.39K | 0.03% | 198 |
|
|
2021
Q2 | $604K | Buy |
2,632
+185
| +8% | +$42.5K | 0.03% | 204 |
|
|
2021
Q1 | $457K | Buy |
2,447
+27
| +1% | +$5.04K | 0.03% | 212 |
|
|
2020
Q4 | $409K | Buy |
+2,420
| New | +$409K | 0.03% | 209 |
|